Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury

Kidney International

Volumn 75, Issue 8, 2009, Pages 809-823

  Kim, Minjae ^a   Chen, Sean W C ^a   Park, Sang Won ^a   Kim, Mihwa ^a   D'agati, Vivette D ^a   Yang, Jay ^a   Lee, H Thomas ^a  

^a Columbia University ^*  (United States)

Author keywords

Acute kidney injury; Acute renal failure; Apoptosis; Inflammation; Lentivirus; Necrosis

Indexed keywords

ADENOSINE A1 RECEPTOR; CREATININE; ENHANCED GREEN FLUORESCENT PROTEIN; F ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; INTERCELLULAR ADHESION MOLECULE 1; KERATINOCYTE DERIVED CHEMOKINE; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOSKELETON; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE NECROSIS; KNOCKOUT MOUSE; MOUSE; NEPHRITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPERFUSION INJURY; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ACTINS; ANIMALS; CYTOSKELETON; GENE THERAPY; GENETIC VECTORS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, ADENOSINE A1; REPERFUSION INJURY;

EID: 63949083856     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.699     Document Type: Article

References (54)

1. Jones DR, Lee HT. Protecting the kidney during critical illness. Curr Opin Anaesthesiol 2007; 20: 106-112.
2. Tang IY, Murray PT. Prevention of perioperative acute renal failure: what works? Best Pract Res Clin Anaesthesiol 2004; 18: 91-111.
3. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 1817-1831.
4. Rabb H, O'Meara YM, Maderna P et al. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997; 51: 1463-1468.
5. Sutton TA, Molitoris BA. Mechanisms of cellular injury in ischemic acute renal failure. Semin Nephrol 1998; 18: 490-497.
6. Molitoris BA. Actin cytoskeleton in ischemic acute renal failure. Kidney Int 2004; 66: 871-883.
7. Heyman SN, Brezis M, Reubinoff CA et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988; 82: 401-412.
8. Epstein FH, Brezis M, Silva P et al. Physiological and clinical implications of medullary hypoxia. Artif Organs 1987; 11: 463-467.
9. Lee HT, Gallos G, Nasr SH et al. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111.
10. Lee HT, Xu H, Nasr SH et al. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306.
11. Lee HT, Emala CW. Protein kinase C and G(i/o) proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 2001; 12: 233-240.
12. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000; 278: F380-F387.
13. Lee HT, Kim M, Jan M et al. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 2007; 71: 1249-1261.
14. Jablonski P, Howden BO, Rae DA et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
15. Lee HT, Emala CW. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury. J Am Soc Nephrol 2002; 13: 2753-2761.
16. Arrigo AP, Firdaus WJ, Mellier G et al. Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression. Methods 2005; 35: 126-138.
17. Arrigo AP. Hsp27: novel regulator of intracellular redox state. IUBMB Life 2001; 52: 303-307.
18. Ramesh G, Reeves WB. Inflammatory cytokines in acute renal failure. Kidney Int Suppl 2004; 91: S56-S61.
19. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 2007; 97: 738-747.
20. Joo JD, Kim M, Horst P et al. Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol 2007; 293: F1847-F1857.
21. Garrido C, Bruey JM, Fromentin A et al. HSP27 inhibits cytochrome cdependent activation of procaspase-9. FASEB J 1999; 13: 2061-2070.
22. Bruey JM, Ducasse C, Bonniaud P et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2: 645-652.
23. Wyttenbach A, Sauvageot O, Carmichael J et al. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 2002; 11: 1137-1151.
24. Samali A, Robertson JD, Peterson E et al. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones 2001; 6: 49-58.
25. Paul C, Manero F, Gonin S et al. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 2002; 22: 816-834.
26. Weber NC, Toma O, Wolter JI et al. Mechanisms of xenon- and isofluraneinduced preconditioning-a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 2005; 146: 445-455.
27. Landry J, Huot J. Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heat-shock protein of 27 kDa (Hsp27). Biochem Soc Symp 1999; 64: 79-89.
28. Huot J, Houle F, Spitz DR et al. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 1996; 56: 273-279.
29. Van Why SK, Mann AS, Ardito T et al. Hsp27 associates with actin and limits injury in energy depleted renal epithelia. J Am Soc Nephrol 2003; 14: 98-106.
30. Shelden EA, Borrelli MJ, Pollock FM et al. Heat shock protein 27 associates with basolateral cell boundaries in heat-shocked and ATP-depleted epithelial cells. J Am Soc Nephrol 2002; 13: 332-341.
31. Agmon Y, Dinour D, Brezis M. Disparate effects of adenosine A1- and A2- receptor agonists on intrarenal blood flow. Am J Physiol 1993; 265: F802-F806.
32. Munger KA, Jackson EK. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am J Physiol 1994; 267: F783-F790.
33. Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol 2006; 10: 229-235.
34. Hartman ZC, Appledorn DM, Amalfitano A. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 2008; 132: 1-14.
35. Yin M, Wheeler MD, Connor HD et al. Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney. J Am Soc Nephrol 2001; 12: 2691-2700.
36. Nakamura A, Imaizumi A, Yanagawa Y et al. Beta(2)-adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Nephrol 2004; 15: 316-325.
37. Sandovici M, Henning RH, van Goor H et al. Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury. Kidney Int 2008; 73: 1364-1373.
38. Sandovici M, Deelman LE, van Goor H et al. Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury. J Gene Med 2007; 9: 1024-1032.
39. Doerschug K, Sanlioglu S, Flaherty DM et al. First-generation adenovirus vectors shorten survival time in a murine model of sepsis. J Immunol 2002; 169: 6539-6545.
40. Gusella GL, Fedorova E, Hanss B et al. Lentiviral gene transduction of kidney. Hum Gene Ther 2002; 13: 407-414.
41. Gusella GL, Fedorova E, Marras D et al. In vivo gene transfer to kidney by lentiviral vector. Kidney Int 2002; 61: S32-S36.
42. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998; 9: 457-463.
43. Zager RA. Sepsis-associated acute renal failure: some potential pathogenetic and therapeutic insights. Nephrol Dial Transplant 1994; 9(Suppl 4): 164-167.
44. Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J Gastroenterol 2007; 13: 5552-5559.
45. Rosen S, Stillman IE. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol 2008; 19: 871-875.
46. Rosen S, Heyman SN. Difficulties in understanding human 'acute tubular necrosis': limited data and flawed animal models. Kidney Int 2001; 60: 1220-1224.
47. Sun D, Samuelson LC, Yang T et al. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 2001; 98: 9983-9988.
48. Lee HT, Jan M, Bae SC et al. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 2006; 290: F1367-F1375.
49. Lee HT, Emala CW, Joo JD et al. Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock 2007; 27: 373-379.
50. Lee HT, Kim M, Kim J et al. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007; 27: 416-424.
51. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965; 17: 381-387.
52. Lee HT, Xu H, Siegel CD et al. Local anesthetics induce human renal cell apoptosis. Am J Nephrol 2003; 23: 129-139.
53. Molitoris BA. Putting the actin cytoskeleton into perspective: pathophysiology of ischemic alterations. Am J Physiol 1997; 272: F430-F433.
54. Molitoris BA. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. Am J Physiol 1991; 260: F769-F778.